ROMAD TrueProactive a next generation cyber defence software for European SMEs
Modern society is increasingly dependent on electronic networks and information systems, but the evolution of ICT systems has also brought rapid growth of criminal activity that threatens citizens, businesses, governments and crit...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto TrueProactive
Duración del proyecto: 1 meses
Fecha Inicio: 2018-07-09
Fecha Fin: 2018-08-31
Líder del proyecto
ROMAD HOLDING LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Modern society is increasingly dependent on electronic networks and information systems, but the evolution of ICT systems has also brought rapid growth of criminal activity that threatens citizens, businesses, governments and critical infrastructures. The cost of cybercrime reached €500B (2015) and continues to increase. Furthermore, according to EC Cybersecurity research ransomware attacks have increased by 300% since 2015. This situation with exponentially growing cybercrime numbers demonstrates that traditional antivirus protects only from KNOWN malware variants, but criminals are always one step ahead. This leaves the end users (mainly SME’s and home users) and thus European economy highly vulnerable. ROMAD Holding Ltd is a cyber security startup company originally founded in 2012 in Ukraine (registered in Cyprus). Our ground-breaking next generation endpoint defence platform will be the first able to address the burning needs of the industry. The key innovation of True Proactive™ lays on the concept of malware families and their immutable behavioral characteristics. Our platform genetically sequencing entire malware families, enabling proactively detect and block new strains. We aim at bringing Romad True Proactive™ to the market in 2021. Further testing and intensive development of core architecture, processing apparatus and the Genome database must be performed before commercialisation. During current (Phase 1) project we will re-evaluate the commercialization plan, incl. identifying target entry markets, identify most suitable distributors on each of entry markets, define strategy how to approach them.
Finally, based on our Initial business plan a business opportunity of €115M arises for ROMAD Holding Ltd. We plan to make cumulative profit of €46M and hire at least 40 new employees by the 5th year of commercialization. Our mission is to give TrueProactive™ v2.0 for free of charge to schools and universities.